Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
22 hedge funds and large institutions have $2.15M invested in Histogen Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 6 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
8% less funds holding
Funds holding: 24 → 22 (-2)
28% less capital invested
Capital invested by funds: $2.99M → $2.15M (-$835K)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$58.7K |
| 2 |
NDSI
Newman Dignan & Sheerar Inc
Providence,
Rhode Island
|
+$44.4K |
| 3 |
VF
Virtu Financial
New York
|
+$34.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$29.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$24.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$101K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$51.2K |
| 3 |
Goldman Sachs
New York
|
-$34K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$9K |
| 5 |
N
Natixis
Paris,
France
|
-$7.7K |
HSTO Hedge Fund Activity: Q3 2021 in Review
22 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q3 2021, worth a combined $2.15M — down 28% from $2.99M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of HSTO and 4 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 9 added.
The largest buyer was Northern Trust, adding an estimated $58.7K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $101K sold.
- 22 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q3 2021, down from 24 in Q2 2021.
- Funds reported $2.15M of Histogen Inc. Common Stock stock for Q3 2021, down 28% quarter-over-quarter.
- 4 funds opened new Histogen Inc. Common Stock positions in Q3 2021 and 6 closed out, a net change of -2 holders.
- The largest Histogen Inc. Common Stock buyer in Q3 2021 was Northern Trust, an estimated $58.7K added.
- The largest Histogen Inc. Common Stock seller in Q3 2021 was Renaissance Technologies, an estimated $101K sold.
Based on aggregated 13F filings for Q3 2021.